Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Article
Functional and Structural Characterization of Isookanin Inhibition at the Human 5-HT3A Receptor
Jaehui Yang†, Jeongyeon Yun†, Myungmi Moon, Yejin Kim, Hye Duck Yeom, Virginia Njoki Kamau, Mee-Hyun Lee, Gihyun Lee , Junho H Lee
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2026 Volume 49 Issue 11 Pages 1923-1932

Details
Abstract

Isookanin, a phenolic flavonoid found in Bidens pilosa, is described as a multifunctional bioactive compound with reported antioxidant and anti-inflammatory activities and potential antidiabetic effects, including suppression of carbohydrate-digesting enzymes such as α-amylase. During our initial screening, isookanin emerged as a strong inhibitor of the human 5-HT3A receptor, which led us to characterize its pharmacological profile in detail. Human 5-HT3A receptors were heterologously expressed in Xenopus laevis oocytes, and serotonin (5-HT)-evoked currents were recorded using a two-electrode voltage clamp to determine how isookanin modulates receptor function. To define the molecular basis of this modulation, we combined in silico docking or structural modeling with targeted site-directed mutagenesis. Isookanin produced a marked and readily reversible reduction of 5-HT–induced currents, with inhibition increasing with concentration and showing noncompetitive behavior with respect to 5-HT. The effect was not altered by membrane potential, indicating a voltage-independent mechanism. Concentration–response analysis yielded an IC50 of 6.1 ± 0.3 μM. Structure-guided mutational testing further supported specific receptor determinants for isookanin action, identifying residues at positions 221 and 224 (F221 and E224) as key contributors to sensitivity. Collectively, these results establish isookanin as a potent antagonist of the human 5-HT3A receptor and delineate its inhibitory mechanism at both functional and molecular levels.

Fullsize Image
Content from these authors
© 2026 The Author(s).
Published by The Pharmaceutical Society of Japan

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
Previous article
feedback
Top